The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IBC 2024 | Non-drug interventions in SMM/MGUS: diet & lifestyle
Urvi Shah, MD, Memorial Sloan Kettering Cancer Center, New York City, NY, shares insights into her work exploring non-drug interventions for smoldering multiple myeloma (SMM) and monoclonal gammopathy of undetermined significance (MGUS). Dr Shah discusses the link between various dietary patterns and the risk of developing multiple myeloma, and gives an overview of ongoing studies in this space, including the NUTRIVENTION-3 trial (NCT05640843). This session was filmed at IBC 2024, held in Lisbon, Portugal.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
